ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm To Commence Phase 2 Ross River Virus Clinical Trial
Published: 10/07/17, 08:28am (AEST)•2 pages